UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Reduces Stock Position in Plexus Corp. (NASDAQ:PLXS)

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC decreased its holdings in shares of Plexus Corp. (NASDAQ:PLXS - Free Report) by 5.7% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 59,789 shares of the technology company's stock after selling 3,615 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned about 0.22% of Plexus worth $8,174,000 as of its most recent SEC filing.

Other large investors have also recently modified their holdings of the company. Quest Partners LLC increased its position in Plexus by 36,700.0% during the 2nd quarter. Quest Partners LLC now owns 368 shares of the technology company's stock valued at $38,000 after buying an additional 367 shares in the last quarter. Innealta Capital LLC acquired a new position in shares of Plexus in the 2nd quarter valued at about $51,000. Farther Finance Advisors LLC grew its holdings in Plexus by 89.4% during the third quarter. Farther Finance Advisors LLC now owns 464 shares of the technology company's stock worth $63,000 after acquiring an additional 219 shares during the period. Advisors Asset Management Inc. lifted its holdings in Plexus by 85.0% in the third quarter. Advisors Asset Management Inc. now owns 664 shares of the technology company's stock valued at $91,000 after acquiring an additional 305 shares during the period. Finally, GAMMA Investing LLC boosted its position in Plexus by 190.1% in the 3rd quarter. GAMMA Investing LLC now owns 760 shares of the technology company's stock worth $104,000 after purchasing an additional 498 shares in the last quarter. Institutional investors own 94.45% of the company's stock.

Plexus Stock Down 0.8 %

NASDAQ:PLXS traded down $1.37 during mid-day trading on Tuesday, hitting $166.57. The stock had a trading volume of 197,145 shares, compared to its average volume of 135,709. The company has a market capitalization of $4.51 billion, a PE ratio of 41.54 and a beta of 0.90. The stock has a 50-day simple moving average of $150.96 and a two-hundred day simple moving average of $128.99. The company has a current ratio of 1.51, a quick ratio of 0.71 and a debt-to-equity ratio of 0.07. Plexus Corp. has a twelve month low of $90.18 and a twelve month high of $170.07.

Plexus (NASDAQ:PLXS - Get Free Report) last announced its quarterly earnings results on Wednesday, October 23rd. The technology company reported $1.85 earnings per share for the quarter, beating analysts' consensus estimates of $1.55 by $0.30. The firm had revenue of $1.05 billion during the quarter, compared to analysts' expectations of $1.01 billion. Plexus had a net margin of 2.82% and a return on equity of 9.51%. Plexus's quarterly revenue was up 2.6% compared to the same quarter last year. During the same period in the previous year, the company earned $1.44 earnings per share. On average, equities research analysts anticipate that Plexus Corp. will post 6.14 EPS for the current year.

Insider Transactions at Plexus

In other news, insider Michael J. Running sold 539 shares of Plexus stock in a transaction that occurred on Wednesday, November 20th. The shares were sold at an average price of $155.87, for a total transaction of $84,013.93. Following the completion of the sale, the insider now directly owns 1,030 shares in the company, valued at approximately $160,546.10. This trade represents a 34.35 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Patrick John Jermain sold 5,045 shares of the firm's stock in a transaction on Monday, October 28th. The shares were sold at an average price of $143.13, for a total value of $722,090.85. Following the completion of the transaction, the chief financial officer now owns 24,602 shares of the company's stock, valued at approximately $3,521,284.26. This represents a 17.02 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 32,591 shares of company stock worth $5,143,375. Company insiders own 2.39% of the company's stock.

Analyst Upgrades and Downgrades

PLXS has been the topic of several research analyst reports. StockNews.com raised Plexus from a "hold" rating to a "buy" rating in a report on Monday, November 18th. Benchmark lifted their price target on shares of Plexus from $150.00 to $165.00 and gave the company a "buy" rating in a research note on Monday, October 28th. KeyCorp initiated coverage on shares of Plexus in a report on Tuesday, October 22nd. They set a "sector weight" rating on the stock. Stifel Nicolaus lifted their target price on shares of Plexus from $136.00 to $150.00 and gave the company a "hold" rating in a research report on Tuesday. Finally, Needham & Company LLC upped their price target on shares of Plexus from $144.00 to $162.00 and gave the stock a "buy" rating in a research report on Friday, October 25th. Three analysts have rated the stock with a hold rating and three have given a buy rating to the company's stock. According to MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $147.25.

Plexus Company Profile

Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.